MTOR/AMPK Signaling in the Brain: Cell Metabolism, Proteostasis and Survival

Overview

Journal Curr Opin Toxicol

Date 2018 Nov 13

PMID 30417160

Citations 49

Authors

Carla Garza-Lombo

Annika Schroder

Elsa M Reyes-Reyes

Rodrigo Franco

Affiliations

Soon will be listed here.

Abstract

The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding the role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.

Citing Articles

RyR1 Is Involved in the Control of Myogenesis.

Tourel A, Reynaud-Dulaurier R, Brocard J, Faure J, Marty I, Petiot A Cells. 2025; 14(3).

PMID: 39936950 PMC: 11817019. DOI: 10.3390/cells14030158.

Antioxidant and longevity inducing properties of coconut water on human dermal fibroblasts.

Nakorn S, Dokduang H, Namwat N, Klanrit P, Wangwiwatsin A, Promraksa B Heliyon. 2025; 10(24):e41010.

PMID: 39759299 PMC: 11696670. DOI: 10.1016/j.heliyon.2024.e41010.

The Neuroprotective Effects of Caffeine in a Neonatal Hypoxia-Ischemia Model are Regulated through the AMPK/mTOR Pathway.

Bernis M, Burkard H, Bremer A, Grzelak K, Zweyer M, Maes E Int J Biol Sci. 2025; 21(1):251-270.

PMID: 39744433 PMC: 11667826. DOI: 10.7150/ijbs.101087.

Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.

Jiang M, Fang H, Tian H Theranostics. 2025; 15(1):155-188.

PMID: 39744225 PMC: 11667227. DOI: 10.7150/thno.103376.

Gut-brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration.

Trisal A, Singh I, Garg G, Jorwal K, Singh A 3 Biotech. 2024; 15(1):25.

PMID: 39735610 PMC: 11680542. DOI: 10.1007/s13205-024-04187-0.

References

Mihaylova M, Shaw R . The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011; 13(9):1016-23. PMC: 3249400. DOI: 10.1038/ncb2329. View

Feehan R, Shantz L . Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation. Cell Signal. 2016; 28(8):798-809. PMC: 4899167. DOI: 10.1016/j.cellsig.2016.03.013. View

Dagon Y, Hur E, Zheng B, Wellenstein K, Cantley L, Kahn B . p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab. 2012; 16(1):104-12. PMC: 3407689. DOI: 10.1016/j.cmet.2012.05.010. View

Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buee L . AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Sci Rep. 2016; 6:26758. PMC: 4882625. DOI: 10.1038/srep26758. View

Berry M, Ahmed Z, Morgan-Warren P, Fulton D, Logan A . Prospects for mTOR-mediated functional repair after central nervous system trauma. Neurobiol Dis. 2015; 85:99-110. DOI: 10.1016/j.nbd.2015.10.002. View

Dulovic M, Jovanovic M, Xilouri M, Stefanis L, Harhaji-Trajkovic L, Kravic-Stevovic T . The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Neurobiol Dis. 2013; 63:1-11. DOI: 10.1016/j.nbd.2013.11.002. View

Seixas da Silva G, Melo H, Lourenco M, Lyra E Silva N, de Carvalho M, Alves-Leon S . Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. J Biol Chem. 2017; 292(18):7395-7406. PMC: 5418041. DOI: 10.1074/jbc.M116.753525. View

Pastor M, Garcia-Yebenes I, Fradejas N, Perez-Ortiz J, Mora-Lee S, Tranque P . mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem. 2009; 284(33):22067-22078. PMC: 2755931. DOI: 10.1074/jbc.M109.033100. View

Imai Y, Gehrke S, Wang H, Takahashi R, Hasegawa K, Oota E . Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 2008; 27(18):2432-43. PMC: 2543051. DOI: 10.1038/emboj.2008.163. View

10.

Ishizuka Y, Kakiya N, Witters L, Oshiro N, Shirao T, Nawa H . AMP-activated protein kinase counteracts brain-derived neurotrophic factor-induced mammalian target of rapamycin complex 1 signaling in neurons. J Neurochem. 2013; 127(1):66-77. DOI: 10.1111/jnc.12362. View

11.

Porstmann T, Santos C, Griffiths B, Cully M, Wu M, Leevers S . SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008; 8(3):224-36. PMC: 2593919. DOI: 10.1016/j.cmet.2008.07.007. View

12.

Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C . Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife. 2016; 5. PMC: 4846388. DOI: 10.7554/eLife.13378. View

13.

Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F . The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Neuron. 2013; 78(1):94-108. PMC: 3784324. DOI: 10.1016/j.neuron.2013.02.003. View

14.

Ravikumar B, Vacher C, Berger Z, Davies J, Luo S, Oroz L . Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004; 36(6):585-95. DOI: 10.1038/ng1362. View

15.

Gu Y, Albuquerque C, Braas D, Zhang W, Villa G, Bi J . mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Mol Cell. 2017; 67(1):128-138.e7. PMC: 5521991. DOI: 10.1016/j.molcel.2017.05.030. View

16.

Diaz-Garcia C, Mongeon R, Lahmann C, Koveal D, Zucker H, Yellen G . Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake. Cell Metab. 2017; 26(2):361-374.e4. PMC: 5559896. DOI: 10.1016/j.cmet.2017.06.021. View

17.

Hwang J, Gertner M, Pontarelli F, Court-Vazquez B, Bennett M, Ofengeim D . Global ischemia induces lysosomal-mediated degradation of mTOR and activation of autophagy in hippocampal neurons destined to die. Cell Death Differ. 2016; 24(2):317-329. PMC: 5299717. DOI: 10.1038/cdd.2016.140. View

18.

Wong M . Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013; 36(2):40-50. PMC: 3880546. DOI: 10.4103/2319-4170.110365. View

19.

Crino P . The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol. 2016; 12(7):379-92. DOI: 10.1038/nrneurol.2016.81. View

20.

Wang X, Meng D, Chang Q, Pan J, Zhang Z, Chen G . Arsenic inhibits neurite outgrowth by inhibiting the LKB1-AMPK signaling pathway. Environ Health Perspect. 2010; 118(5):627-34. PMC: 2866677. DOI: 10.1289/ehp.0901510. View